In connection with his resignation and departure from Gyre Therapeutics, Inc., Dr. Charles Wu also resigned as a member of the board of directors of the Company. and as a member of the board of directors of Beijing Continent Pharmaceuticals Co. Ltd., of which the Company holds an indirect controlling interest, each effective on January 15, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.72 USD | -0.69% | +1.69% | -57.96% |
1st Jan change | Capi. | |
---|---|---|
-57.96% | 924M | |
+34.56% | 51.07B | |
-8.19% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+11.98% | 26.35B | |
-18.76% | 19.46B | |
+40.58% | 13.58B | |
+28.78% | 12.46B | |
-3.85% | 11.75B |
- Stock Market
- Equities
- GYRE Stock
- News Gyre Therapeutics, Inc.
- Gyre Therapeutics, Inc. and Beijing Continent Pharmaceuticals Co., Ltd. Announce the Resignation of Charles Wu as Member of the Board of Directors. Effective on January 15, 2024